Roseland, NJ, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that the Company successfully integrated Suno AI and ElevenLabs into their artificial intelligence solution for game developers and publishers, Gaxos Labs. "We are pleased to welcome Suno AI and ElevenLabs into our Gaxos Labs ecosystem," said Vadim Mats, CEO of Gaxos. "As we continue on our path to becoming an all-in-one artificial intelligence solution for game developers and publishers, we will add other AI tools to make our product more robust and invaluable." Suno and ElevenLabs offers users the abi

Roseland, NJ, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, announced today that the Company's Board of Directors approved the purchase of up to $1 million in Bitcoin.  "As demand for Bitcoin grows and so does its acceptance as a major and primary asset class, we believe that Bitcoin will serve as a strong treasury reserve asset," said Vadim Mats, CEO of Gaxos. "With recent approval of Bitcoin ETFs and growing support from institutional investors, it is a great addition to our treasury strategy. Its limited supply and inflation-resistant characteristics provide a functional sto

Roseland, NJ, Nov. 05, 2024 (GLOBE NEWSWIRE) --  Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it will participate in the upcoming AI Summit New York on December 11th-12th in New York City. "We are excited to be part of the AI Summit," said Vadim Mats, CEO of Gaxos. "As we engage globally with development communities, gamers, and industry leaders, we continue to forge meaningful relationships that bring value to our AI products." To meet with Gaxos at the conferences or for press inquiries, please email [email protected] About Game Industry Conference Since 2016, The AI Summit Series has ga

Roseland, NJ, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it will participate in the upcoming Game Industry Conference on October 24th - 27th in Poznan, Poland, "We are excited to be part of GIC 2024," said Vadim Mats, CEO of Gaxos. "As we continue to engage globally with development communities, gamers, and industry leaders, we forge meaningful relationships that facilitate growth for our AI offerings." To meet with Gaxos at the conferences or for press inquiries, please email [email protected] About Game Industry Conference The Game Industry Conference

A Media Snippet accompanying this announcement is available by clicking on this link. ROSELAND, N.J., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today revealed the official launch of Gaxos Labs, its cutting-edge artificial intelligence solution for game developers and publishers. Gaxos Labs empowers game developers to accelerate the development process, enhance creativity and increase revenue through its proprietary generative AI asset editor and Unity plugin, and player-facing generative AI offering. By utilizing Gaxos Labs, developers can quickly create, refine, and ma

Roseland, NJ, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQ:GXAI), ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it has entered into a definitive agreement for the exercise of certain existing warrants to purchase an aggregate of 1,256,734 shares of its common stock originally issued in March 2024 and having an original exercise price of $5.50 per share, at a reduced exercise price of $2.58 per share. The issuance and sale of the shares of common stock issuable upon exercise of the existing warrants is registered pursuant to an effective registration statement on Form S-3 (File No. 333-278513).

Roseland, NJ, Sept. 13, 2024 (GLOBE NEWSWIRE) --  Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it will participate in the upcoming Unite 2024 Conference on September 18th - 20th in Barcelona, Spain. "We are excited to be part of Unity's Unite 2024 conference," said Vadim Mats, CEO of Gaxos. "As we engage with development communities, gamers, and industry leaders, we forge meaningful relationships that facilitate growth for our AI offerings." To meet with Gaxos at the conferences or for press inquiries, please email [email protected] About Unite 2024 Conference Unite is Unity's annual confe

Roseland, NJ, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it will participate in the upcoming Devcom Developer Conference on August 18th - Aug 20th and Gamescom Conference on August 21st – 25th in Cologne, Germany. "We are excited to be part of Devcom and Gamescom this year," said Vadim Mats, CEO of Gaxos. "These conferences provide us with a fantastic opportunity to engage with developers, industry leaders, and gamers. We expect to forge meaningful relationships and connections that will help grow our AI product for game developers and publishers."

Significant Milestone as Company Transitions from Development to Revenue Generation. Roseland, NJ, July 30, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced the commercial launch of Gaxos Health and recorded its initial revenue this week. "We are thrilled to announce the commercial launch of Gaxos Health," said Vadim Mats, CEO of Gaxos. "With the rising demand for personalized health services, we strive to make a significant impact and become a leader in the industry. The launch of this business line is integral to our continued mission of delivering value to our shareh

Roseland, NJ, July 24, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has finalized partnerships with premier testing laboratories. "As we move closer to commercial launch, we are incredibly excited about these partnerships, which represent a significant step forward in our ability to offer highly personalized health and wellness solutions," said Vadim Mats, CEO of Gaxos. "By combining our innovative approach with the exceptional capabilities of our testing laboratory partners, we are set to transform the health and wellness experience for our clients

Roseland, NJ, March 13, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it had acquired the rights to use certain AI-enabled technology from a top biohacking app, "Ultiself," in order to facilitate the development of its tech for Gaxos Health. The integration of Ultiself's proprietary technology into Gaxos Health's proposed product offering will enable enhanced customization and user experience aligning with modern-day consumer's demands for custom and efficient solutions. This move is expected to accelerate Gaxos Health's development and help solidify its positio

Roseland, NJ, April 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell. "The addition of top medical talent to our Medical Advisory Board reflects our continued commitment to pursuing a best-in-class solution for Gaxos Health," said Vadim Mats, CEO of Gaxos.AI. "An advisory board of experts in their respective fields will allow to create a better product and advancing our mission of creating value for shareholders." Dr. Eric Margolis, M.D.  is a Board-Ce